PRECISION PHARMACOTHERAPY IN TYPE 2 DIABETES MELLITUS: EVALUATING THE CARDIO-RENAL AND GLYCEMIC EFFICACY OF TARGET-SPECIFIC PATHWAY MODULATION. World Bulletin of Public Health, v. 56, p. 82–84, 26 Mar.2026.